Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Indiana establishes 340B Drug Pricing Program reporting requirements for covered entities

April 02, 2025 | 2025 Senate Enrolled Bills, 2025 Enrolled Bills, 2025 Bills, Indiana Legislation Bills, Indiana


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Indiana establishes 340B Drug Pricing Program reporting requirements for covered entities
On April 2, 2025, Indiana Senate Legislation introduced Senate Bill 118, a significant piece of legislation aimed at enhancing healthcare accessibility for financially and medically indigent individuals. The bill seeks to establish clearer definitions and reporting requirements related to the 340B Drug Pricing Program, which is designed to provide discounted medications to eligible healthcare providers serving low-income patients.

The bill defines "financially indigent" as uninsured or underinsured individuals who qualify for care without financial obligation or at a reduced cost based on hospital criteria aligned with federal poverty guidelines. Similarly, "medically indigent" refers to those whose medical expenses exceed a certain percentage of their annual income after third-party payments, rendering them unable to cover the remaining costs.

One of the key provisions of Senate Bill 118 is the establishment of a new chapter in the Indiana Code that mandates 340B covered entities to report specific information annually to the state. This includes the entity's name, service address, 340B program identification number, and type designation. The aim is to enhance transparency and accountability in the use of the 340B program, ensuring that the benefits reach the intended populations.

The introduction of this bill has sparked discussions among lawmakers and healthcare advocates. Proponents argue that it will improve access to essential medications for vulnerable populations, while critics express concerns about the administrative burden it may place on healthcare providers. Some stakeholders worry that the reporting requirements could divert resources away from patient care.

The implications of Senate Bill 118 extend beyond healthcare access; they touch on economic and social dimensions as well. By potentially lowering medication costs for low-income individuals, the bill could alleviate some financial strain on families and reduce overall healthcare expenditures in the state.

As the legislative process unfolds, experts suggest that the bill's success will depend on balancing the need for accountability with the operational realities faced by healthcare providers. The upcoming debates and amendments will likely shape the final form of the legislation, which could have lasting effects on Indiana's healthcare landscape.

View Bill

This article is based on a bill currently being presented in the state government—explore the full text of the bill for a deeper understanding and compare it to the constitution

View Bill

Sponsors

Proudly supported by sponsors who keep Indiana articles free in 2025

Scribe from Workplace AI
Scribe from Workplace AI